Ambalal Sarabhai Enterprises Ltd (AMBALALSA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 982753, "name": "Ambalal Sarabhai", "stock_name": "Ambalal Sarabhai", "full_name": "Ambalal Sarabhai Enterprises Ltd", "name_url": "stocks-analysis/ambalal-sarabhai", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "31.37", "chg": 0.01, "chgp": "0.03%", "dir": 1, "prev_price": "31.36", "mcapval": "240.40 Cr", "mcap": "Micro Cap", "scripcode": 500009, "symbol": "AMBALALSA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE432A01017", "curr_date": "Jun 25, 12:16 PM", "curr_time": "12:17 PM", "last_traded_at": "Jun 25, 12:16 PM IST", "bse_nse_vol": "38.32 k", "exc_status": "Active", "traded_date": "Jun 25, 2026", "traded_date_str": "2026 06 25", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ambalal-sarabhai-982753-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Ambalal Sarabhai Enterprises Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/ambalal-sarabhai-enterprises-ltd-is-rated-hold-4068874", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AmbalalSarabhai_mojoScore_4068874.png", "date": "2026-06-23 10:10:54", "description": "Ambalal Sarabhai Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Ambalal Sarabhai Enterprises Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/ambalal-sarabhai-enterprises-ltd-downgraded-to-hold-amid-mixed-technical-and-financial-signals-4040568", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AmbalalSarabhai_mojoScore_4040568.png", "date": "2026-06-09 09:04:52", "description": "Ambalal Sarabhai Enterprises Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 8 June 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite positive quarterly financial results, evolving technical signals and valuation considerations have tempered investor enthusiasm, prompting a more cautious stance." }, { "title": "Broad-Based Technical Strength Lifts Ambalal Sarabhai Enterprises Ltd to 52-Week High of Rs 38.85", "link": "https://www.marketsmojo.com/news/stocks-in-action/ambalal-sarabhai-enterprises-ltd-hits-new-52-week-high-at-rs-3885-4030301", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AmbalalSarabhai_priceRelatedfactors_4030301.png", "date": "2026-06-02 09:51:58", "description": "With a decisive intraday surge pushing Ambalal Sarabhai Enterprises Ltd to a fresh 52-week high of Rs 38.85 on 2 Jun 2026, the stock has demonstrated robust momentum amid a broader market backdrop that remains subdued." }, { "title": "Broad-Based Technical Strength Lifts Ambalal Sarabhai Enterprises Ltd to 52-Week High of Rs 38.85", "link": "https://www.marketsmojo.com/news/stocks-in-action/ambalal-sarabhai-enterprises-ltd-hits-new-52-week-high-at-rs-3885-4030300", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AmbalalSarabhai_priceRelatedfactors_4030300.png", "date": "2026-06-02 09:51:58", "description": "With a decisive surge to Rs 38.85 on 2 Jun 2026, Ambalal Sarabhai Enterprises Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally stands out amid a broader market backdrop where the Sensex trades near its 52-week low, underscoring the stock’s relative strength and technical resilience." }, { "title": "Ambalal Sarabhai Enterprises Ltd Gains 7.92%: 4 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/ambalal-sarabhai-enterprises-ltd-gains-792-4-key-factors-driving-the-week-4022922", "imagepath": "", "date": "2026-05-30 13:08:43", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Quality grade upgraded amid mixed financial signals</p>\n <p><strong>26 May:</strong> Golden Cross formation signals potential bullish breakout</p>\n <p><strong>26 May:</strong> Mojo rating upgraded to Hold on improved fundamentals and valuation</p>\n <p><strong>26 May:</strong> Valuation grade upgraded to very attractive, signalling renewed price appeal</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.33.07</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\"..." }, { "title": "Golden Cross Forms in Ambalal Sarabhai Enterprises Ltd — Mixed Technical Signals and Fundamental Context", "link": "https://www.marketsmojo.com/news/stocks-in-action/ambalal-sarabhai-enterprises-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4014799", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmbalalSarabhai_goldencross_4014799.png", "date": "2026-05-26 18:20:08", "description": "The 50-day moving average has crossed above the 200-day moving average for Ambalal Sarabhai Enterprises Ltd, signalling a golden cross on 26 May 2026. Yet, the broader technical indicators and fundamental backdrop present a nuanced picture that tempers the enthusiasm this crossover might otherwise generate." }, { "title": "Ambalal Sarabhai Enterprises Ltd Upgraded to Hold on Improved Fundamentals and Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/ambalal-sarabhai-enterprises-ltd-upgraded-to-hold-on-improved-fundamentals-and-valuation-4013042", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmbalalSarabhai_mojoScore_4013042.png", "date": "2026-05-26 09:04:31", "description": "Ambalal Sarabhai Enterprises Ltd has seen its investment rating upgraded from Sell to Hold, reflecting notable improvements across key parameters including quality, valuation, financial trends, and technical indicators. The upgrade, effective from 25 May 2026, follows a comprehensive reassessment of the company’s fundamentals and market positioning within the Pharmaceuticals & Biotechnology sector." }, { "title": "Ambalal Sarabhai Enterprises Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/ambalal-sarabhai-enterprises-ltd-valuation-shifts-signal-renewed-price-attractiveness-4012472", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmbalalSarabhai_valuationdot_4012472.png", "date": "2026-05-26 08:01:41", "description": "Ambalal Sarabhai Enterprises Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent dip in share price. This change reflects a significant reappraisal of the company’s price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, signalling a potentially compelling entry point for investors within the Pharmaceuticals & Biotechnology sector." }, { "title": "Ambalal Sarabhai Enterprises Ltd Quality Grade Upgraded Amid Mixed Financial Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/ambalal-sarabhai-enterprises-ltd-quality-grade-upgraded-amid-mixed-financial-signals-4009712", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmbalalSarabhai_qualitydot_4009712.png", "date": "2026-05-25 08:00:10", "description": "Ambalal Sarabhai Enterprises Ltd has seen its quality grade improve from below average to average, reflecting a nuanced shift in its business fundamentals. While key profitability metrics such as return on equity (ROE) remain robust, other indicators like return on capital employed (ROCE) and debt levels suggest areas of concern. This article analyses the recent quality parameter changes and what they imply for investors in this pharmaceuticals and biotechnology micro-cap." } ], "total": 160, "sid": "982753", "stock_news_url": "https://www.marketsmojo.com/news/ambalal-sarabhai-enterprises-982753" }, "announcements": [ { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "27-May-2026", "details": "We hereby submit Annual Secretarial Compliance Report for FY 2025-26. Kindly take the same on your records.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "24-May-2026", "details": "We hereby submit clippings of Newspaper. Kindly take the same on your records.", "source": "BSE" }, { "caption": "Results - Financial Results As On 31.03.2026", "datetime": "21-May-2026", "details": "We here by submit Financial Results (Standalone and Consolidated) for the Quarter and Year ended 31.03.2026 along with Auditors Report thereon. Kindly take the same on your records.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Quality grade upgraded amid mixed financial signals

26 May: Golden Cross formation signals potential bullish breakout

26 May: Mojo rating upgraded to Hold on improved fundamentals and valuation

26 May: Valuation grade upgraded to very attractive, signalling renewed price appeal

Week Open

Rs.33.07

Read full news article

Golden Cross Forms in Ambalal Sarabhai Enterprises Ltd — Mixed Technical Signals and Fundamental Context

2026-05-26 18:20:08

The 50-day moving average has crossed above the 200-day moving average for Ambalal Sarabhai Enterprises Ltd, signalling a golden cross on 26 May 2026. Yet, the broader technical indicators and fundamental backdrop present a nuanced picture that tempers the enthusiasm this crossover might otherwise generate.

Read full news article

Ambalal Sarabhai Enterprises Ltd Upgraded to Hold on Improved Fundamentals and Valuation

2026-05-26 09:04:31

Ambalal Sarabhai Enterprises Ltd has seen its investment rating upgraded from Sell to Hold, reflecting notable improvements across key parameters including quality, valuation, financial trends, and technical indicators. The upgrade, effective from 25 May 2026, follows a comprehensive reassessment of the company’s fundamentals and market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Ambalal Sarabhai Enterprises Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-26 08:01:41

Ambalal Sarabhai Enterprises Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent dip in share price. This change reflects a significant reappraisal of the company’s price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, signalling a potentially compelling entry point for investors within the Pharmaceuticals & Biotechnology sector.

Read full news article

Ambalal Sarabhai Enterprises Ltd Quality Grade Upgraded Amid Mixed Financial Signals

2026-05-25 08:00:10

Ambalal Sarabhai Enterprises Ltd has seen its quality grade improve from below average to average, reflecting a nuanced shift in its business fundamentals. While key profitability metrics such as return on equity (ROE) remain robust, other indicators like return on capital employed (ROCE) and debt levels suggest areas of concern. This article analyses the recent quality parameter changes and what they imply for investors in this pharmaceuticals and biotechnology micro-cap.

Read full news article